| Record ID | ia:etoposidevp16cur0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/etoposidevp16cur0000unse/etoposidevp16cur0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/etoposidevp16cur0000unse/etoposidevp16cur0000unse_meta.mrc |
LEADER: 01103cam a2200265 a 4500
001 84000358
003 DLC
005 19860903000000.0
008 840124s1984 flua b 10000 eng
010 $a 84000358 //r86
020 $a0123753503 (alk. paper)
050 0 $aRC271.E76$bE87 1984
082 0 $a616.99/4061$219
245 00 $aEtoposide (VP-16) :$bcurrent status and new developments /$cedited by Brian F. Issell, Franco M. Muggia, Stephen K. Carter ; assisted by Diane Schaefer, Judi Schurig.
260 0 $aOrlando :$bAcademic Press,$c1984.
300 $axix, 355 p. :$bill. ;$c24 cm.
500 $aPapers presented at a symposium held Sept. 15-16, 1983 in New York, N.Y., and sponsored by the New York University Medical Center Postgraduate Medical School.
504 $aIncludes bibliographies.
650 0 $aEtoposide$xCongresses.
650 0 $aCancer$xChemotherapy$xCongresses.
650 0 $aAntineoplastic agents$xCongresses.
700 10 $aIssell, Brian F.
700 10 $aMuggia, Franco M.
700 10 $aCarter, Stephen K.,$d1937-
710 20 $aNew York University.$bPostgraduate Medical School.